Cel-Sci ( Cel-Sci )

Cel-Sci

Cel-Sci's picture

Cel-Sci Press Release and News

Cel-Sci press release, blog etc

12/29/2017 - 14:05 CEL-SCI REPORTS FISCAL 2017 FINANCIAL RESULTS AND CLINICAL & CORPORATE DEVELOPMENTS
12/18/2017 - 15:18 CEL-SCI ANNOUNCES ROBERT WATSON JOINS ITS BOARD OF DIRECTORS
12/11/2017 - 11:48 CEL-SCI REACHES FULL ENROLLMENT IN PIVOTAL PHASE 3 HEAD AND NECK CANCER STUDY
11/13/2017 - 11:13 CEL-SCI ANNOUNCES UPDATE ON ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION
10/10/2017 - 04:54 CEL-SCI GRANTED EUROPEAN PATENT FOR MULTIKINE'S MECHANISM OF ACTION IN MAKING TUMORS 'VISIBLE' TO THE IMMUNE SYSTEM
10/05/2017 - 08:17 CEL-SCI ANNOUNCES UPDATE ON ONGOING ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION
09/19/2017 - 03:54 CEL-SCI ANNOUNCES $1.5 MILLION NIH SBIR GRANT TO SUPPORT DEVELOPMENT OF RHEUMATOID ARTHRITIS VACCINE
08/23/2017 - 08:03 CEL-SCI ANNOUNCES $3.5 MILLION REGISTERED DIRECT OFFERING
08/14/2017 - 04:53 U.S. FDA REMOVES CLINICAL HOLD ON CEL-SCI'S PHASE 3 HEAD & NECK CANCER TRIAL
06/12/2017 - 12:22 CEL-SCI ANNOUNCES REVERSE STOCK SPLIT
06/08/2017 - 07:33 CEL-SCI ANNOUNCES NEW DATA FOR ITS RHEUMATOID ARTHRITIS VACCINE CANDIDATE PUBLISHED IN PEER REVIEWED JOURNAL
06/05/2017 - 05:20 CEL-SCI SUBMITS FDA RESPONSE FOR ITS PHASE 3 HEAD AND NECK CANCER TRIAL
05/16/2017 - 10:44 CEL-SCI SCIENTIST PRESENTS AT AAI - IMMUNOLOGY 2017 MEETING
05/01/2017 - 09:20 CEL-SCI ANNOUNCES $1.51 MILLION REGISTERED DIRECT OFFERING
04/28/2017 - 08:11 CEL-SCI RECEIVES INTENT TO GRANT NOTICE FOR NEW MULTIKINE PATENT FROM THE EUROPEAN PATENT OFFICE
04/12/2017 - 04:18 CEL-SCI SCIENTIST PRESENTS AT THE WORLD VACCINE CONGRESS
03/09/2017 - 07:04 CEL-SCI ANNOUNCES $1.5 MILLION REGISTERED DIRECT OFFERING
03/06/2017 - 11:28 CEL-SCI GIVES UPDATE ON PARTIAL CLINICAL HOLD ON PHASE 3 HEAD AND NECK CANCER STUDY WITH MULTIKINE